# TACROLIMUS
> **ANDA217108** · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2025-02-12
## Drug
- **FDA Application Number:** ANDA217108
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TACROLIMUS
- **Generic name:** TACROLIMUS
- **Active ingredients:** TACROLIMUS
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NEXUS
- **Manufacturer:** Nexus Pharmaceuticals, LLC
- **First approval:** 2025-02-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217108)
---
*MORVS · CC0 1.0*